Key result
In super-obese patients, duodenal switch resulted in a greater percentage of excess body weight loss at 36 months compared to Roux-en-Y gastric bypass.
Why the study?
Does duodenal switch improve weight loss in super-obese patients compared with gastric bypass?
Cohort (n=350)
No
Does duodenal switch improve weight loss in super-obese patients compared with gastric bypass?
In super-obese patients (BMI ≥50 kg/m²), duodenal switch provides superior long-term weight loss outcomes compared to Roux-en-Y gastric bypass with similar 30-day mortality.
Answers are grounded in this paper and cite their sources.
May support duodenal switch in super-obese patients; extends observational data but leaves open need for randomized confirmation.
OBJECTIVES: Although weight loss following Roux-en-Y gastric bypass is acceptable in patients with preoperative body mass index (BMI) between 35 and 50 kg/m, results from several series demonstrate that failure rates approach 40% when BMI is > or =50 kg/m. Here we report the first large single institution series directly comparing weight-loss outcomes in super-obese patients following biliopancreatic diversion with duodenal switch (DS) and Roux-en-Y Gastric Bypass (RYGB). METHODS: All super-obese patients (BMI > or =50 kg/m) undergoing standardized laparoscopic and open DS and RYGB between August 2002 and October 2005 were identified from a prospective database. Two-sample t tests were used to compare weight loss, decrease in BMI, and percentage of excess body weight loss (% EBWL) after surgery. chi analysis was used to determine the rate of successful weight loss, defined as achieving at least 50% loss of excess body weight. RESULTS: A total of 350 super-obese patients underwent DS (n = 198) or RYGB (n = 152) with equal 30-day mortality (DS,1 of 198; RYGB, 0 of 152; P = not significant). The % EBWL at follow-up was greater for DS than RY (12 months, 64.1% vs. 55.9%; 18 months, 71. 9% vs. 62.8%; 24 months, 71.6% vs. 60.1%; 36 months, 68.9% vs. 54.9%; P < 0.05). Total weight loss and decrease in BMI were also statistically greater for the DS (data not shown). Importantly, the likelihood of successful weight loss (EBWL >50%) was significantly greater in patients following DS (12 months, 83.9% vs. 70.4%; 18 months, 90.3% vs. 75.9%; 36 months, 84.2% vs. 59.3%; P < 0.05). CONCLUSIONS: Direct comparison of DS to RYGB demonstrates superior weight loss outcomes for DS.
No takes yet. Share an insight, caveat, or question.
Prachand et al. (2006) conducted a cohort in Super-obesity (n=350). Biliopancreatic diversion with duodenal switch (DS) vs. Roux-en-Y Gastric Bypass (RYGB) was evaluated on Percentage of excess body weight loss (% EBWL) at 36 months (p=< 0.05). In super-obese patients, duodenal switch resulted in a greater percentage of excess body weight loss at 36 months compared to Roux-en-Y gastric bypass.
Synapse has enriched 10 related papers. Consider them for comparative context: